55 Results

People

  1. Zhou
    Zhou
  2. Iasonos
    Iasonos
  3. Aghajanian
    Aghajanian
  4. Abu-Rustum
    Abu-Rustum
  5. Soslow
    Soslow
  6. Grisham
    Grisham
  7. Hensley
    Hensley
  8. Konner
    Konner
  9. Zivanovic
    Zivanovic
  10. Chi
    Chi

Groups

  1. Solid Tumor Oncology Division (55)
  2. Biostatistics Service (51)
  3. Epidemiology and Biostatistics (51)
  4. Gynecologic Medicine Service (39)
  5. Surgery (39)
  6. Gynecologic Oncology Disease Management Team (17)
  7. Survivorship Research (14)
  8. Early Drug Development Service (9)
  9. Radiation Oncology, Department of (9)
  10. Gynecologic Medicine Service (8)
Refine Results
  1. "Qin Zhou"
  2. "Solid Tumor Oncology Division"
  3. "Journal article"
Formats
  1. Journal Article (55)
Groups
  1. Solid Tumor Oncology Division (55)
  2. Biostatistics Service (51)
  3. Epidemiology and Biostatistics (51)
  4. Gynecologic Medicine Service (39)
  5. Surgery (39)
  6. Gynecologic Oncology Disease Management Team (17)

More Groups

People
  1. Qin Zhou (55)
  2. Alexia Iasonos (45)
  3. Carol Aghajanian (26)
  4. Nadeem Abu-Rustum (21)
  5. Roisin O'Cearbhaill (18)
  6. Dennis Chi (16)

More People

Years
  1. 2020 (9)
  2. 2019 (3)
  3. 2018 (3)
  4. 2017 (3)
  5. 2016 (5)
  6. 2015 (5)

More Years

Publications
  1. Gynecologic Oncology (22)
  2. International Journal of Gynecological Cancer (12)
  3. Annals of Surgical Oncology (3)
  4. Annals of Surgery (2)
  5. Cancer (2)
  6. Journal for ImmunoTherapy of Cancer (2)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. Lippincott Williams & Wilkins (14)
  3. American Association for Cancer Research (3)
  4. Springer (3)
  5. American Society of Clinical Oncology (2)
  6. Biomed Central Ltd (2)

More Publishers

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: What is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Liu, Y. L.; Zhou, Q. C.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G.; Broach, V.; O'Cearbhaill, R.; Konner, J. A.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q. C.; Iasonos, A.; Filippova, O. T.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G.; Broach, V.; Ocearbhaill, R.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
    Journal Article

    Friedman, C. F.; Snyder Charen, A.; Zhou, Q.; Carducci, M. A.; Buckley De Meritens, A.; Corr, B. R.; Fu, S.; Hollmann, T. J.; Iasonos, A.; Konner, J. A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • BRCA mutations, homologous DNA repair deficiency, tumor mutational burden, and response to immune checkpoint inhibition in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Selenica, P.; Zhou, Q.; Iasonos, A.; Callahan, M.; Feit, N. Z.; Boland, J.; Vazquez-Garcia, I.; Mandelker, D.; Zehir, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Journal Article

    Boland, J. L.; Zhou, Q.; Iasonos, A. E.; O'Cearbhaill, R. E.; Konner, J.; Callahan, M.; Friedman, C.; Aghajanian, C.; Sabbatini, P.; Zamarin, D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Characteristics and outcome of AKT1(E17K)-mutant breast cancer defined through AACR Project GENIE, a clinicogenomic registry
    Journal Article

    Smyth, L. M.; Zhou, Q.; Nguyen, B.; Yu, C.; Lepisto, E. M.; Arnedos, M.; Hasset, M. J.; Lenoue-Newton, M. L.; Blauvelt, N.; Dogan, S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
    Journal Article

    Liu, Y. L.; Filippova, O. T.; Zhou, Q.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V. A.; O'Cearbhaill, R. E.; more...
    Journal of Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save